Company
United StatesPublic company, NYSE: BIOBio-Rad Laboratories, Inc. (NYSE: BIO), Redmond, WA – FDA Inspections
Inspection records and compliance data for Bio-Rad Laboratories, Inc. in Redmond, Washington. 7 FDA inspections on record, last inspected December 06, 2021. Publicly traded as NYSE: BIO.
Company Profile
This profile covers Bio-Rad Laboratories, Inc. based in Redmond, Washington, United States.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 0
- VAI
- 3
- NAI
- 4
- Form 483s
- 0
- Warning letters
- 0
First inspected November 17, 2011. Last inspected December 6, 2021.
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 6, 2021 | NAI | Biologics · Blood and Blood Products | 1160908 |
| October 7, 2019 | NAI | Biologics · Blood and Blood Products | 1114316 |
| June 23, 2016 | VAI | Biologics · Blood and Blood Products | 991581 |
| April 23, 2014 | VAI | Biologics · Blood and Blood Products | 873872 |
| December 4, 2013 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 856743 |
| January 31, 2012 | VAI | Biologics · Blood and Blood Products | 762458 |
| November 17, 2011 | NAI | Medical Devices & Rad Health · Compliance: Devices | 755961 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bio-Rad Laboratories, Inc.
Stock ticker
BIO
Exchange
NYSE
Share price
$369.30
Market cap
$9.9B
Price as of
November 6, 2026
FEI Number
3022521
Address
6565 185th Ave Ne, Redmond, Washington 98052, United States
Country
United States
ID: 6a2685c0-89a3-4569-8ea9-b58eec29d644